跳至主要内容
临床试验/NCT01873820
NCT01873820已完成不适用

A Randomized, Double-blind, Crossover Study Comparing the Tolerance of Two Forms of Vitamin C in Acid Sensitive Adults

NBTY, Inc.1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2008年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
NBTY, Inc.
入组人数
50
试验地点
1
主要终点
Change from Baseline Gastrointestinal Symptom Rating Scale at 5 and 10 days

研究概览

简要总结

The purpose of this study is to compare the tolerance of two forms of vitamin C in adults with sensitivity to acidic foods.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Healthy as determined by laboratory results and medical history
  • •Females not of child bearing potential
  • •Self-reported sensitivity to acidic foods
  • •Agrees to consume a low vitamin C diet

排除标准

  • •Pregnant, breastfeeding, or planning to become pregnant during the trial
  • •Use of medications known to interact with vitamin C or cause epigastric effects
  • •Use of supplements containing containing vitamin C
  • •Duodenal ulcer or gastric ulcer, gastritis, hiatus hernia, or gastroesophageal reflux disease (GERD) within past 3 months
  • •Use of antacids and/or acid suppressors within 4 weeks of randomization
  • •History of irritable bowel syndrome and related disorders
  • •Alcohol use > 2 standard alcoholic drinks per day; alcohol or drug abuse within the past year
  • •History of cardiac disease within the past 6 months
  • •History of or current diagnosis of cancer
  • •Uncontrolled hypertension
  • •Unstable renal and/or liver disease
  • •History of kidney stones
  • •Unstable psychiatric disorder
  • •History of or current immunocompromise
  • •History of hemoglobinopathies
  • •Participation in another clinical research trial <30 days
  • •Abnormal liver function
  • •Serum creatinine > 1.5 x upper limit of normal (ULN)
  • •Anemia of any etiology
  • •Uncontrolled and/or untreated thyroid disorder
  • •BMI ≥ 35 kg/m2
  • •Unstable medications <30 days
  • •Allergy or sensitivity to test article ingredients
  • •Cognitively impaired and/or unable to give informed consent

研究组 & 干预措施

Ascorbic acid -> calcium ascorbate

Experimental

干预措施: Ascorbic acid (Dietary Supplement)

Ascorbic acid -> calcium ascorbate

Experimental

干预措施: Calcium ascorbate (Dietary Supplement)

Calcium ascorbate -> ascorbic acid

Experimental

干预措施: Ascorbic acid (Dietary Supplement)

Calcium ascorbate -> ascorbic acid

Experimental

干预措施: Calcium ascorbate (Dietary Supplement)

结局指标

主要结局

Change from Baseline Gastrointestinal Symptom Rating Scale at 5 and 10 days

时间窗: 0, 5 and 10 days

次要结局

未报告次要终点

研究者

发起方
NBTY, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验